Find

Search Newsmax Health Search Newsmax Search Web
Newsletters Video Shop Contact Us Archives
 
Newsmax Moneynews Newsmax.TV
 
 
Headline Story  

Olive Oil Protects Against Alzheimer’s

Monday, November 30, 2009 7:51 AM

By Sylvia Booth Hubbard

Print this Page  

Forward Page  Forward Page

Email Us  Email Us

Oleocanthal, a compound that occurs naturally in extra-virgin olive oil, can alter the structure of toxic proteins in the brain that contribute to Alzheimer’s disease.

A study by researchers at Northwestern University and the Monell Chemical Senses Center found that the change inhibits the ability of the toxic proteins, called ADDLs, to damage nerves in the brain.

“Binding of ADDLs to nerve synapses is thought to be a crucial first step in Alzheimer’s disease,” study co-leader William L. Klein, professor of neurobiology and physiology in Northwestern’s Weinberg College of Arts and Sciences, said in a statement. “Oleocanthal alters ADDL structure in a way that deters the protein from binding to synapses.

“Our findings may help identify effective preventative measures and lead to improved therapeutics in the fight against Alzheimer’s disease,” added co-researcher Paul A.S. Breslin, a sensory psychobiologist at the Monell Center.

Synapses allow nerve cells to send information to each other. ADDLs bind to neural synapses in the brains of Alzheimer’s patients and interrupt the function of nerve cells. Eventually, cells die, which leads to memory loss.

The researchers found that olive oil compound changed the structure of ADDLs by increasing their size and affected their ability to bind to synapses of hippocampal neurons.

The hippocampus, a part of the brain involved in memory and learning, is one of the first areas affected by Alzheimer’s disease. The study discovered that oleocanthal also protected synapses from damage caused by ADDLs. In addition, oleocanthal was found to increase the effectiveness of antibodies, which can be used to bind and attack ADDLs, increasing the possibility of creating effective therapies based on antibodies.

© 2009 Newsmax. All rights reserved.

 

 
 
   
   
   
       Privacy Policy  |  Terms & conditions  |  Contact Us

PLEASE NOTE: All information presented in Newsmaxhealth.com and Newsmax.com is for informational purposes only. It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes only. All information presented on our websites should not be construed as medical consultation or instruction. You should take no action solely on the basis of this publication’s contents. Readers are advised to consult a health professional about any issue regarding their health and well-being. While the information found on our websites is believed to be sensible and accurate based on the author’s best judgment, readers who fail to seek counsel from appropriate health professionals assume risk of any potential ill effects. The opinions expressed in Newsmaxhealth.com and Newsmax.com do not necessarily reflect those of Newsmax Media. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course of action